Invitae Corporation (NVTA) |
|
2.485 0.005 (0.2%)
|
02-08 09:32 |
|
Open: |
2.52 |
Pre. Close: |
2.48 |
|
High:
|
2.51 |
Low:
|
2.475 |
|
Volume:
|
206,271 |
Market Cap:
|
604(M) |
|
|
|
Technical analysis |
as of: 2023-02-07 4:30:35 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 3.43 One year: 4.01 |
| Support: |
Support1: 2.19 Support2: 1.74 |
| Resistance: |
Resistance1: 2.94 Resistance2: 3.43 |
| Pivot: |
2.53 |
| Moving Average: |
MA(5): 2.53  MA(20): 2.49
MA(100): 2.46 MA(250): 3.92 |
| MACD: |
MACD(12,26): 0 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 41.9 %D(3): 48.6 |
| RSI: |
RSI(14): 52.1 |
| 52-week: |
High: 11.39 Low: 1.66 |
| Average Vol(K): |
3-Month: 8,309 (K) 10-Days: 10,454 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ NVTA ] has closed above bottom band by 36.7%. Bollinger Bands are 62.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.58 - 2.59 |
2.59 - 2.6 |
|
Low:
|
2.35 - 2.36 |
2.36 - 2.38 |
|
Close:
|
2.45 - 2.48 |
2.48 - 2.51 |
|
Company Description |
|
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. |
Headline News |
Wed, 08 Feb 2023
Invitae Stock: Approach With Caution - The Motley Fool
Tue, 07 Feb 2023
Great West Life Assurance Co. Can Purchases New Shares in ... - MarketBeat
Mon, 06 Feb 2023
Is Invitae Corp (NVTA) Stock at the Top of the Diagnostics & Research Industry? - InvestorsObserver
Fri, 03 Feb 2023
Sumitomo Mitsui Trust Holdings Cuts Stake in Invitae (NVTA) - Nasdaq
Thu, 02 Feb 2023
AMC, NVTA and OPEN are among pre market gainers - Seeking Alpha
Wed, 01 Feb 2023
Do Analysts Agree Wednesday on Invitae Corp (NVTA) Stock's Target Price? - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
226 (M) |
| Shares Float |
234 (M) |
|
% Held by Insiders
|
1 (%) |
|
% Held by Institutions
|
84.3 (%) |
|
Shares Short
|
42,990 (K) |
|
Shares Short P.Month
|
38,320 (K) |
Stock Financials |
|
EPS
|
-4.48 |
|
EPS Est Next Qtl
|
-0.51 |
|
EPS Est This Year
|
-2.35 |
|
EPS Est Next Year
|
-1.34 |
|
Book Value (p.s.)
|
10.63 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-168.8 |
|
Return on Assets (ttm)
|
-14.5 |
|
Return on Equity (ttm)
|
-204.6 |
|
Qtrly Rev. Growth
|
17.5 |
|
Gross Profit (p.s.)
|
0.49 |
|
Sales Per Share
|
2.21 |
|
EBITDA (p.s.)
|
-3.26 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-623 (M) |
|
Levered Free Cash Flow
|
-375 (M) |
Stock Valuations |
|
PE Ratio
|
-0.56 |
|
PEG Ratio
|
-0.2 |
|
Price to Book value
|
0.23 |
|
Price to Sales
|
1.12 |
|
Price to Cash Flow
|
-0.91 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
